BOULDER, Colo. , Nov. 18, 2024 /PRNewswire/ — Bolder BioTechnology, Inc. announced today that the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has exercised its option to fund the second year of Contract NIH-BAA-75N93023C00011, entitled…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Experienced position leader to helm KP Medical Foundation, supporting care delivery operations in Colorado and Washington OAKLAND, Calif., Nov. 29, 2022 /PRNewswire/ — Kaiser Permanente has announced Paul Minardi, MD, as executive vice president and […]
While pledging to save “hundreds of millions of dollars” by allowing cheaper Canadian imports of “the same drugs,” Florida Gov. Ron DeSantis on Friday hinted at potentially taking FDA to court over his state’s plan […]
They say the third time’s a charm. Click here to view original post
Copyright © 2026 Biotech Networks
